Dr. Franco Vizeacoumar Featured in SHRF's "Research for Health" Magazine
The research program of Dr. Vizeacoumar was featured in the December-2015 Issue 3 of "Research for Health", a magazine produced by the Saskatchewan Health Research Foundation.
The research program of Dr. Vizeacoumar was featured in the December-2015 Issue 3 of "Research for Health", a magazine produced by the Saskatchewan Health Research Foundation.
"Expression of calcineurin, calpastatin and heat shock proteins during ischemia and reperfusion"
Dr. Franco Vizeacoumar was presented the Saskatchewan Health Research Foundation 2015 Top Biomedical Establishment Grant Award for his new Operating Grant to establish his research program in Saskatchewan.
"Novel myristoylation of the sperm-specific hexokinase 1 isoform regulates its atypical localization"
"The Q Motif Is Involved in DNA Binding but Not ATP Binding in ChlR1 Helicase"
Congratulations Kalpana on winning the OMICS International Best Poster titled 'Transgene IL-6 engineered dendritic cell-stimulated CD8+ T-cells - Role in Potent Immmunotherapy'. The 6th International Conference on Biomarkers & Clinical Research was held on August 31 - September 2, 2015 in Toronto, Ontario.
Dr. Yuliang (coPI: Dr. Erique Lukong) were awarded a new three-year operating grant from the Canadian Breast Cancer Foundation - Prairies/NWT Region. The title of their project is: “HAGE: A potential biomarker and therapeutic target for triple-negative breast cancer”.
"Potent immunotherapy against well-established thymoma using adoptively transferred transgene IL-6-engineered dendritic cell-stimulated CD8+ T-cells with prolonged survival and enhanced cytotoxicity"
"Tracing the footprints of the breast cancer oncogene BRK - Past till present"
Her talk will take place on August 20, 2015
Congratulations to Chelsea Cunningham (Vizeacoumar Lab).
"Transgenic 4-1BBL-engineered vaccine stimulates potent Gag-specific therapeutic and long-term immunity via increased priming of CD44+CD62Lhigh IL-7R+ CTLs with up- and downregulation of anti- and pro-apoptosis genes"
Congratulations to Shuangshuang Li (Vizeacoumar Lab), the recipient of a Saskatchewan Health Research Foundation Postdoctoral Fellowship, a two-year award. Shuangshuang’s project is titled: “Targeting epigenetic modification to eradicate cancer stem cells”.
Congratulations to Shari Smith (Anderson Lab), the recipient of a Saskatchewan Health Research Foundation Postdoctoral Fellowship, a two-year award. Shari’s project is titled: “Synthetic lethal approaches to metastatic breast cancer therapy”.
Dr. Franco Vizeacoumar was awarded a 3-year grant from the Saskatchewan Health Research Foundation. Title: ‘Synthetic dosage Lethality of polo-like kinase 1 in colorectal cancer.’
Dr. Franco Vizeacoumar was awarded a 2-year grant from Prostate Cancer Canada. Title: ‘Validating synthetic dosage lethal interactions of PLK1 in androgen-insensitive prostate cancer cells.’
The second Saskatchewan Cancer Research Conference was held June 25 in Saskatoon and was well attended with just over 100 registered participants from a wide range of disciplines.
"N-terminal region of the catalytic domain of human N-myristoyltransferase 1 acts as an inhibitory module"
"Differential expression of mannose-6-phosphate receptor regulates T cell contraction."
"Enhanced protective immunity derived from dendritic cells with phagocytosis of CD40 ligand transgene-engineered apoptotic tumor cells via increased dendritic cell maturation"
Shaina Templeton (Vizeacoumar Lab) was awarded an NSERC Undergraduate Summer Research Award to support her studies during the summer months in the Vizeacoumar Lab.
Chelsea Cunningham (Vizeacoumar Lab) was awarded an NSERC Undergraduate Summer Research Award to support her studies during the summer months in the Vizeacoumar Lab.
Dr. Jim Xiang was awarded a prostate cancer grant from the Swift Current chapter of the TELUS Motorcycle Ride for Dad to carry out a project called: “Novel HER2-specific exosome-targeted T cell vaccine for HER2-positive prostate cancer bone metastasis”.
Conference to be held June 25, 2015
Deborah is nominated in the Research and Technology category, which recognizes women for excellence or discovery in science, research, or technology, and who are role models in their careers and community involvement.
Dr. Keith Bonham (co-PI: Dr. Franco Vizeacoumar) was awarded a 2-year grant from the Saskatchewan Cancer Agency. Title: 'A systematic approach to define chemical genetic interactions of DHAC inhibitors in breast cancer cells.'
"Innate and adoptive immune cells contribute to natural resistance to systemic metastasis of b16 melanoma"
"HER2-directed therapy: current treatment options for HER2-positive breast cancers"
"A distinct triplex DNA unwinding activity of ChlR1 helicase"
Chenlu Dai (Lukong lab) passed her MSc defence on Jan 22, 2015.
Dr. Franco Vizeacoumar and co-applicant Dr. Brian Eames were awarded a total of $1.26 Million dollars for a High throughput Molecular Imaging Platform through a new CFI Infrastructure grant ($503,729 from CFI).